Iconovo awarded Top Drug Delivery Device company 2020 by Medtech Outlook

  Iconovo has been recognized as a leading solution provider of drug delivery devices by Medtech Outlook when the magazine listed 10 companies…

First ICOres® patent in the United States

United States Patent and Trademark Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation…

Iconovo guides regarding value of generic Seebri® and Ultibro® for ICOcap® formulations

Iconovo announced July 8th that a regional licensing agreement had been signed with BNC Korea regarding the development of two inhalation capsule formulations…

Iconovo signs regional licensing agreement for ICOcap® formulations with BNC Korea

Iconovo announce that the company has signed a know-how license agreement granting BNC Korea Co Ltd the exclusive rights to use the know-how to manufacture…

Stevanato to invest in ICOcap® manufacturing

Stevanato announced in their industrial plan for 2020 – 2023 that they intend to invest almost Euro 400 million in manufacturing and R&D programs…

Iconovo release briefing document for ICOpre® development

Today, Iconovo released a briefing document on its homepage covering the market opportunity, patent situation, ICOpre® product features and partnering…

Positive decision about a Chinese ICOres® patent

The Chinese Patent Agency has announced the intention to grant a patent regarding Iconovo’s inhalation device, ICOres Iconovo has previously granted…

Iconovo i samarbetsprojekt med Malmö Universitet om porösa läkemedelsbärare (only in Swedish)

Projektet Porösa läkemedelsbärare för inhalerbara terapier har nyligen startat upp Det är finansierat av KK-stiftelsen och är ett samarbete mellan…

Capsule inhaler ICOcap™ from Iconovo CE-marked for clinical trials

Iconovo announce that the capsule-based dry powder inhaler ICOcap™ is CE-marked for use in clinical trials ICOcap™ is now available for customers…

Positive patent news for Iconovo’s multidose inhaler

Positive patent news for Iconovo’s multidose inhaler The European Patent Organization, EPO, has announced the intention to grant a patent regarding…